Antibe Therapeutics Inc. Banner Image

Antibe Therapeutics Inc.

  • Ticker ATE
    Exchange TSX-V More
  • Industry Biotechnology More
  • Sector Healthcare More
Antibe Therapeutics Inc. Logo Image
  • 11-50 Employees
  • Based in Toronto, Ontario
Antibe Therapeutics is a publicly traded biotechnology company pursuing a breakthrough advance in the treatment of inflammation. Their drug pipeline addresses major markets in non-addictive management of chronic and post-surgical pain. Antibe’s lead drug, now in late Phase 2 trials, is demonstrating unprecedented safety in the treatment of chronic pain, a condition that affects more thanMore 50 million Americans alone. Their second pipeline drug is intended to replace a range of opioids, addressing a vast and pressing public health concern. Their third drug is a safer daily aspirin -- delivering anti-stroke and anti-cancer benefits without damage to the digestive tract.
Antibe Therapeutics Inc.

Most Recent Annual Report

Antibe Therapeutics Inc.
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports